What are the clinical features or factors that suggest treatment should be switched or stopped for people with diabetic macular oedema? For a short explanation of why the committee made this ...

Diabetic macular edema remains an important cause of vision loss among patients with diabetes mellitus. Improved control of blood pressure and blood sugar, as well as photocoagulation, are ...

“OCU200 has the potential to change the treatment landscape for DME, diabetic retinopathy (DR), and wet age-related macular degeneration (wet AMD) with its unique mechanism of action, binding th ...

In people experiencing a rapid, substantial reduction in HbA1c, what is the risk of short-term progression of diabetic retinopathy or diabetic macular oedema, and is there a risk of long-term visual ...

2 University of Colorado Health Sciences Center, Denver, CO, USA Aim: To investigate the use of intravitreal triamcinolone acetonide (IVTA) for the treatment of diabetic macular oedema (DMO ...

The patients were diagnosed with type 1 or type 2 diabetes mellitus ... A Cirrus HD-OCT 4000 (software Version 6.0) was used to obtain the macular images. The patients placed their chins in ...

The following is a summary of “Evaluation of macular ... diabetic retinopathy (PDR)). Participants were categorized based on glycosylated hemoglobin A1c and fundus photography. Retinal oximetry was ...

EYE-103 is under clinical development by Eyebiotech and currently in Phase III for Diabetic Macular Edema. According to GlobalData, Phase III drugs for Diabetic Macular Edema have a 62% phase ...

Ed Holloway has been CEO of the Macular Society for only six months ... founders and he describes to In Touch about a new form of OCT scanner they are developing, with the aim of empowering ...

Specifically, Eylea is used to treat the following in adults wet age-related macular degeneration (AMD) macular edema caused by a blockage in the retinal vein diabetic retinopathy diabetic macular ...